Skip to main content
PALTC24 - AMDA Annual Conference Main banner
Purchase conference recordings
Purchase 2024 conference recordings
Back
Evaluation

Clinical Medicine

(MO17) Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis, Bleeding, Oh My!

Monday, March 11, 2024
3:30 PM – 5:00 PM CT
Room: 303
CMD Clinical Credit Recording
CME: (1.5) MOC: (1.5) CMD Clinical: (1.5) NP Pharmacology Hours (.5)
Disclosure(s):
Monica Ott, MD, CMD: No financial relationships to disclose.
Todd Sobol, MD, FACP, CMD: No relevant financial relationships.
Karl M. Dauphinais, MD, MSS, FACP, CMD: No financial relationships to disclose.
Michelle M. Graham, PharmD, BCPS: No financial relationships to disclose.
This session will discuss how to evaluate combinations of oral anticoagulants and antiplatelets prescribed to an individual patient. Algorithms will be utilized to demonstrate how and when to reduce (or add) medications. Four case-based scenarios (atrial fibrillation on anticoagulation requiring percutaneous coronary intervention; on antiplatelet with new atrial fibrillation; venous thromboembolism requiring percutaneous coronary intervention; on antiplatelet with new venous thromboembolism) will be utilized for an interactive session discussing best approaches to discussing medication optimization with patients, families, and specialists. A pharmacist will provide additional perspectives.

Learning Objectives:

At the completion of this session, learners will be able to:
  • Determine which antithrombotic medication to GDR first.
  • Discuss family/patient barriers to deprescribing.
  • Demonstrate a successful deprescribing conversation with cardiologist.
  • Utilize algorithms to determine appropriate duration of antithrombotic therapy.